I-Mab
ANTI-LAG-3 ANTIBODIES AND USES THEREOF

Last updated:

Abstract:

The present disclosure provides antibodies that bind Lymphocyte Activation Gene-3 (LAG-3). Also provided are methods of stimulating an immune response, inhibiting growth of tumor cells, and treating an autoimmune, inflammatory, or viral disease.

Status:
Application
Type:

Utility

Filling date:

18 Nov 2019

Issue date:

5 Mar 2020